Ernexa Therapeutics selected for Emerging Track at 2026 Cell & Gene Meeting on the Mesa

Ernexa Therapeutics selected for the Emerging Track at the 2026 Cell & Gene Meeting on the Mesa, highlighting ERNA-101 and its focused oncology strategy.